V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20203480 | 20088428 | 1.69 | 61.85 | Palliative (P) | 2017-04-11 | 2017-04-11 | FEC | N | N | PHITT | 101053316 |
| 20203506 | 20088429 | 0 | 0 | Palliative (P) | 2016-05-20 | 2016-06-13 | Azacitidine | 02 | N | RALTITREXED | 101426598 |
| 20203547 | 20088430 | 1.63 | 66 | Palliative (P) | 2019-09-19 | 2019-09-26 | ACTICCA-1 Trial | 02 | N | BENDAMUSTINE + RITUXIMAB | 100936424 |
| 20203627 | 20088431 | null | null | Palliative (P) | 2021-10-05 | 2021-10-08 | EEF or EOF | 02 | N | SCOPE2 TRIAL | 101042890 |
| 20203668 | 20088432 | 1.74 | 83 | Neo-adjuvant (N) | 2020-03-16 | 2020-03-17 | ESPAC-4 TRIAL | N | N | CVP R | 101698016 |
| 20203679 | 20088433 | 0 | 0 | Palliative (P) | 2019-10-29 | 2019-11-12 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 2 | N | MCX | 101039595 |
| 20203786 | 20088434 | 1.45 | 53.5 | Palliative (P) | null | 2021-06-05 | CISPLATIN + TEYSUNO | 01 | N | CHOP R | 100395429 |
| 20203794 | 20088435 | 1.77 | 71 | 03 | 2018-07-06 | 2018-07-24 | ESPAC-4 TRIAL | N | N | IRINOTECAN | 100679328 |
| 20203839 | 20088436 | 1.68 | 70 | Palliative (P) | 2018-10-05 | 2018-10-06 | Cisplatin + Vinorelbine (IV) | 01 | N | PEMBROLIZUMAB | 101501743 |
| 20203844 | 20088437 | 1.7 | 91.7 | Adjuvant (A) | 2020-10-10 | 2020-10-17 | Capecitabine+Cisplatin+Streptozocin | 02 | N | CISPLATIN + TEYSUNO | 100156914 |
| 20203961 | 20088438 | 1.79 | 71 | 03 | 2019-03-27 | 2019-04-16 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | ATEZOLIZUMAB | 100699246 |
| 20204002 | 20088439 | 1.78 | 78.6 | Palliative (P) | 2017-05-02 | 2017-05-03 | EVEROLIMUS | 02 | N | IBRUTINIB | 101176113 |
| 20204093 | 20088441 | null | null | Adjuvant (A) | 2018-04-26 | 2018-05-08 | Rituximab | 02 | N | BENDAMUSTINE + OBINUTUZUMAB | 101870964 |
| 20204109 | 20088442 | 1.7 | 89 | 03 | 2019-04-04 | 2019-04-05 | Capecitabine + Streptozocin | 02 | null | HYDROXYCARBAMIDE | 100726984 |
| 20204125 | 20088443 | 1.69 | 77.2 | 03 | 2018-06-15 | 2018-06-23 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | ABIRATERONE | 100128969 |
| 20204130 | 20088444 | 1.62 | 47 | null | 2016-11-13 | 2016-11-13 | EEF or EOF | 02 | N | ECARBOX | 100501841 |
| 20204196 | 20088445 | 1.87 | 107.5 | 03 | null | 2016-12-14 | Capecitabine+Cisplatin+Streptozocin | null | N | ACTICCA-1 TRIAL | 101749305 |
| 20204310 | 20088447 | 1.82 | 78 | Palliative (P) | 2017-12-13 | 2018-01-09 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | DOCETAXEL | 100137389 |
| 20204380 | 20088448 | 1.78 | 75.6 | Palliative (P) | null | 2019-04-24 | OXALIPLATIN | null | N | IRINOTECAN | 100099922 |
| 20204408 | 20088449 | 1.74 | 69 | null | 2017-12-02 | 2017-12-07 | OXALIPLATIN | 02 | Y | NOT MATCHED | 101403143 |
| 20204417 | 20088450 | 1.47 | 64.6 | Palliative (P) | 2017-12-03 | 2017-12-03 | CARBOPLATIN + FLUOROURACIL | 02 | N | GEMCITABINE + PACLITAXEL | 100936282 |
| 20204423 | 20088451 | 0 | 0 | Palliative (P) | 2018-02-24 | 2018-03-03 | FOXFIRE TRIAL | null | N | AZACITIDINE | 100383333 |
| 20204433 | 20088452 | 1.73 | 72.3 | Curative (C) | 2015-08-03 | 2015-08-16 | Paclitaxel albumin (Abraxane) 21day | 02 | N | ABC-08 TRIAL | 100354441 |
| 20204466 | 20088454 | 1.64 | 60.08 | 03 | 2016-08-15 | 2016-08-15 | SCOPE 2 TRIAL | 02 | N | IRINOTECAN | 101045666 |
| 20204510 | 20088455 | 1.53 | 51.5 | Adjuvant (A) | null | 2019-03-05 | ACTICCA-1 Trial | null | N | AZACITIDINE | 101478155 |
| 20204639 | 20088456 | 1.57 | 92.2 | null | 2019-06-19 | 2019-06-19 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | IBRUTINIB | 101760712 |
| 20204719 | 20088458 | 1.75 | 86 | Adjuvant (A) | 2018-08-28 | 2018-09-27 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | Y | N | OXALIPLATIN | 100246611 |
| 20204742 | 20088459 | 1.86 | 76.6 | Palliative (P) | 2018-03-23 | 2018-03-26 | Docetaxel | 02 | N | PACLITAXEL | 100327205 |
| 20204845 | 20088460 | 1.77 | 49 | Palliative (P) | 2019-10-21 | 2019-10-21 | EOF | 02 | N | CARBOPLATIN + RT | 100673378 |
| 20204902 | 20088461 | 1.88 | 65 | Palliative (P) | 2019-12-16 | 2020-01-14 | Everolimus 10mg | 02 | N | NIVOLUMAB | 100363845 |
| 20204904 | 20088462 | 1.76 | null | Palliative (P) | 2020-01-08 | 2020-01-11 | FCarboSt | 01 | N | NOT MATCHED | 100737462 |
| 20204918 | 20088463 | 1.64 | 88 | 03 | 2018-08-21 | 2018-08-22 | Cisplatin + Vinorelbine (PO) | 02 | N | SCOPE2 TRIAL | 101127140 |
| 20204931 | 20088464 | 1.66 | 70.8 | Palliative (P) | 2018-09-16 | 2018-10-14 | GC Int Guide Excranial GermCell JEB | 02 | N | ACELARATE TRIAL | 101609792 |
| 20204955 | 20088465 | 1.8 | 56.2 | 03 | 2021-01-01 | 2021-01-20 | NEO-AEGIS TRIAL | 02 | N | RUXOLITINIB | 100856300 |
| 20205006 | 20088466 | 1.56 | 91.7 | 03 | 2018-05-10 | 2018-05-23 | MITOMYCIN | 02 | N | GO2 TRIAL | 100404195 |
| 20205017 | 20088467 | 1.75 | 75.5 | 03 | null | 2018-02-02 | IPILIMUMAB + NIVOLUMAB | null | N | EVEROLIMUS | 100045594 |
| 20205077 | 20088468 | 1.63 | 89.7 | Adjuvant (A) | 2019-07-14 | 2019-07-16 | FOXTROT TRIAL | N | Y | TEMOZOLOMIDE | 101388799 |
| 20205115 | 20088469 | 1.75 | 74 | 03 | 2018-04-22 | 2018-05-18 | null | 02 | N | PLATO TRIAL | 101497520 |
| 20205133 | 20088470 | 1.8 | 80 | Palliative (P) | 2021-07-07 | 2021-07-25 | PEMBROLIZUMAB | 02 | N | CARBOPLATIN + FLUOROURACIL | 100488742 |
| 20205252 | 20088471 | 1.7 | 65 | 03 | 2020-10-28 | 2020-11-04 | SCOPE 2 TRIAL | 02 | N | PANITUMUMAB | 101853630 |
| 20205274 | 20088472 | 1.78 | 66 | Palliative (P) | 2018-05-15 | 2018-05-20 | CAP + RT | 02 | N | CYCLOPHOSPHAMIDE | 100302250 |
| 20205348 | 20088473 | 1.82 | 120.2 | 03 | null | 2018-04-15 | BEP 3 day | 02 | null | CAPECITABINE + CETUXIMAB + OXALIPATIN | 101059876 |
| 20205393 | 20088474 | 1.66 | null | Adjuvant (A) | 2019-09-18 | 2019-10-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100502456 |
| 20205425 | 20088475 | null | 68.6 | Palliative (P) | 2016-01-29 | 2016-02-05 | GO2 TRIAL | 02 | N | SCOPE2 TRIAL | 101035569 |
| 20205510 | 20088476 | 1.71 | 62 | 03 | 2018-03-13 | 2018-03-14 | ACELARATE Trial | 02 | N | GEMCARBO | 101192417 |
| 20205527 | 20088477 | 1.59 | 64 | 03 | 2016-03-26 | 2016-04-08 | PEMBROLIZUMAB | 01 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101319002 |
| 20205619 | 20088478 | 1.63 | 83.8 | 03 | 2018-07-03 | 2018-07-24 | Hydroxycarbamide | null | N | CARBO + FLUOROURACIL | 101747743 |
| 20205674 | 20088479 | 1.65 | 93 | 03 | 2018-07-16 | 2018-07-23 | EEF or EOF | N | N | HYDROXYCARBAMIDE | 101791858 |
| 20205748 | 20088480 | 1.47 | 119 | Adjuvant (A) | 2017-05-30 | 2017-06-03 | Gemcitabine + Paclitaxel | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 100908183 |
| 20205791 | 20088482 | 1.75 | 76 | 03 | 2021-05-12 | 2021-05-16 | null | 02 | Y | CAPECITABINE + STREPTOZOCIN | 100837431 |